city_wh_b


Acknowledgements

 

Baltimore Buprenorphine Initiative

Instructions for Physicians who would like to obtain a waiver to prescribe Buprenorphine

Step 1: Enroll in Online Training course via: Online Registration or Paper Registration

Step 2: After receiving an email with your UserID and Password, complete the online training course within 3 months

Step 3: Complete and Submit the Data 2000 Waiver Application (Online Application; Paper Application )

Questions? Contact:

Vanessa Kuhn
Buprenorphine Program Coordinator
Baltimore Substance Abuse Systems, Inc.

One North Charles Street., Ste 1600
Baltimore, MD 21201-3718
(410) 637-1900 ext.286
Fax: (410) 649-1911
vkuhn@bsasinc.org

Baltimore City Health Department is proud to announce the Baltimore Buprenorphine Initiative. This collaborative effort with Baltimore HealthCare Access and Baltimore Substance Abuse Systems will dramatically increase substance abuse treatment options in Baltimore.

 

For decades, Baltimore has had one of the highest rates of heroin addiction in the nation and the demand for heroin treatment exceeds supply. We are bringing together substance abuse treatment centers, community health centers and primary care physicians to collectively join the fight against heroin addiction in Baltimore City.

 

The Baltimore Buprenorphine Initiative Interim Progress Report, July 2007

-Appendices to Interim Report

 

The Baltimore Buprenorphine Initiative 2nd Interim Progress Report, June 2008

 

Report of the Grand Jury for Baltimore City, January 2008 Term

 

Baltimore City Buprenorphine Initiative Earns National Recognition

 

The project has three major components:

 

1. Recruiting physicians across the city to obtain a waiver to prescribe buprenorphine. Free training will be provided to eligible physicians so they can obtain a waiver to prescribe buprenorphine. 

 

2. Drug Treatment. Six substance abuse treatment centers in Baltimore City funded by Baltimore Substance Abuse Systems will provide drug treatment including dose induction, stabilization, and continuance on buprenorphine along with intensive outpatient counseling to opioid dependent patients.

 

3. Extended buprenorphine therapy.  BHCA staff are working closely with substance abuse treatment centers to enroll clients into available public benefits programs and transferring stabilized patients with pharmacy benefits to community-based physicians in community health centers and other settings.